Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/MALDI-TOF/TOF and data validation by routine clinical assays

Electrophoresis

Volumn 27, Issue 8, 2006, Pages 1641-1650

  Huang, Hong Lei ^a   Stasyk, Taras ^a   Morandell, Sandra ^a   Dieplinger, Hans ^a   Falkensammer, Gerda ^a   Griesmacher, Andrea ^a   Mogg, Maurice ^b   Schreiber, Martin ^b   Feuerstein, Isabel ^c   Huck, Christian W ^c   Stecher, Guenther ^c   Bonn, Guenther K ^c   Huber, Lukas A ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Biomarker; Breast cancer; Immunoaffinity depletion; Mass spectrometry; Two dimensional differential gel electrophoresis

Indexed keywords

AFFINITY CHROMATOGRAPHY; ANTIGEN-ANTIBODY REACTIONS; BIOMARKERS; DIAGNOSIS; DISEASES; LIPOPROTEINS;

APOLIPOPROTEIN A-I; BREAST CANCER; GEL ELECTROPHORESIS; IMMUNOAFFINITY; IMMUNOAFFINITY DEPLETION; ISOFORMS; SERUM LEVELS; SERUM SAMPLES; TWO-DIMENSIONAL; TWO-DIMENSIONAL DIFFERENTIAL GEL ELECTROPHORESIS;

MASS SPECTROMETRY;

ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN C3; BIOLOGICAL MARKER; DYE; HAPTOGLOBIN; HEMOGLOBIN; IMMUNOGLOBULIN G; ISOPROTEIN; PROTEIN ANTIBODY; TRANSFERRIN;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DIAGNOSTIC TEST; DOWN REGULATION; EXPERIMENTAL STUDY; FEMALE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MENOPAUSE; MOLECULAR WEIGHT; PROTEIN DENATURATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SCREENING TEST; STANDARD; STATISTICAL SIGNIFICANCE; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; VALIDATION STUDY;

EID: 33646250180     PISSN: 01730835     EISSN: 15222683     Source Type: Journal    
DOI: 10.1002/elps.200500857     Document Type: Article

References (40)

1. Parkin, D. M., Bray, F., Ferlay, J., Pisani, P., CA Cancer J. Clin. 2005, 55, 74-108.
2. Omenn, G. S., Proteomics 2004, 4, 1235-1240.
3. Kennedy, S., Toxicol. Lett. 2001, 120, 379-384.
4. Venkitaraman, A. R., New Engl. J. Med. 2003, 348, 1917-1919.
5. Yao, J., Polyak, K., Breast Cancer Res. 2004, 6, 201-203.
6. Hughes-Davies, L., Huntsman, D., Ruas, M., Fuks, F. et al., Cell 2003, 115, 523-535.
7. D'Alessandro, R., Roselli, M., Ferroni, P., Mariotti, S. et al., Breast Cancer Res. Treat. 2001, 68, 9-19.
8. Martoni, A., Zamagni, C., Bellanova, B., Zanichelli, L. et al., Eur. J. Cancer 1995, 31A, 1615-1621.
9. Huang, H. L., Stasyk, T., Morandell, S., Mogg, M. et al., Electrophoresis 2005, 26, 2843-2849.
10. Görg, A., Obermaier, C., Boguth, G., Weiss, W., Electrophoresis 1999, 20, 712-717.
11. Görg, A., Obermaier, C., Boguth, G., Harder, A. et al., Electrophoresis 2000, 21, 1037-1053.
12. Stasyk, T., Morandell, S., Bakry, R., Feuerstein, I. et al., Electrophoresis 2005, 26, 2850-2854.
13. Hellman, U., Exs 2000, 88, 43-54.
14. Pollak, D., Weitzdoerfer, R., Yang, Y. W., Prast, H. et al., Neurochem. Int. 2005, 46, 19-29.
15. Somiari, R. I., Somiari, S., Russell, S., Shriver, C. D., J. Chromatogr. B 2005, 815, 215-225.
16. Yanagisawa, K., Shyr, Y., Xu, B. J., Massion, P. P. et al., Lancet 2003, 362, 433-439.
17. Conrads, T. P., Fusaro, V. A., Ross, S., Johann, D. et al., Endocr. Relat. Cancer 2004, 11, 163-178.
18. Xiao, Z., Prieto, D., Conrads, T. P., Veenstra, T. D., Issaq, H. J., Mol. Cell Endocrinol. 2005, 230, 95-106.
19. Tonge, R., Shaw, J., Middleton, B., Rowlinson, R. et al., Proteomics 2001, 1, 377-396.
20. Gade, D., Thiermann, J., Markowsky, D., Rabus, R., J. Mol. Microbiol. Biotechnol. 2003, 5, 240-251.
21. Gharbi, S., Gaffney, P., Yang, A., Zvelebil, M. J. et al., Mol. Cell Proteomics 2002, 1, 91-98.
22. Zhang, Z., Bast, R. C., Jr., Yu, Y., Li, J. et al., Cancer Res. 2004, 64, 5882-5890.
23. Kuesel, A. C., Kroft, T., Prefontaine, M., Smith, I. C., Int. J. Cancer 1992, 52, 341-346.
24. Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R. et al., Nature 2004, 431, 461-466.
25. Song, G., Ouyang, G., Bao, S., J. Cell Mol. Med. 2005, 9, 59-71.
26. Yu, B., Li, S. Y., An, P., Zhang, Y. N. et al., World J. Gastroenterol. 2004, 10, 2652-2656.
27. McGuire, K. A., Davidson, W. S., Jonas, A., J. Lipid Res. 1996, 37, 1519-1528.
28. Tricerri, M. A., Behling Agree, A. K., Sanchez, S. A., Jonas, A., Biochemistry 2000, 39, 14682-14691.
29. Karathanasis, S. K., Proc. Natl. Acad. Sci. USA 1985, 82, 6374-6378.
30. Vergnes, L., Baroukh, N., Ostos, M. A., Castro, G. et al., Arterioscler. Thromb. Vasc. Biol. 2000, 20, 2267-2274.
31. Mainous, A. G., III, Gill, J. M., Everett, C. J., Ann. Fam. Med. 2005, 3, 131-137.
32. Balkwill, F., Coussens, L. M., Nature 2004, 431, 405-406.
33. Mantovani, A., Nature 2005, 435, 752-753.
34. Diamandis, E. P., J. Natl. Cancer Inst. 2004, 96, 353-356.
35. Reizenstein, P., Med. Oncol. Tumor Pharmacother. 1991, 8, 229-233.
36. Langlois, M. R., Martin, M. E., Boelaert, J. R., Beaumont, C. et al., Clin. Chem. 2000, 46, 1619-1625.
37. Langlois, M. R., Delanghe, J. R., Clin. Chem. 1996, 42, 1589-1600.
38. Bowman, B. H., Kurosky, A., Adv. Hum. Genet. 1982, 12, 189-261; 453-184.
39. Awadallah, S. M., Atoum, M. F., Clin. Chim. Acta 2004, 341, 17-21.
40. Weinberg, E. D., Eur. J. Cancer Prev. 1996, 5, 19-36.